Informations nutritionnelles

Dose journalière : 4 gélules Nombre de doses par boîte: 30	Quantité par dose
Extrait de la partie aérienne de chanca piedra (Phyllanthus niruri)	500 mg
Extrait de la partie aérienne de prêle des champs (Equisetum arvense)	200 mg
Extrait de racine de pissenlit (Taraxacum officinale)	200 mg
Extrait de fruit de noni (Morinda citrifolia)	200 mg
Hexaphosphate d’inositol	300 mg
Glycinate de magnésium	150 mg
Pyridoxal-5-phosphate	20 mg
Autres ingrédients : gomme d’acacia, farine de riz blanc. AJR en magnésium: 5,64%

Conseils d'utilisation

Adultes. Prendre 2 gélules le matin et 2 gélules le soir.

Pas encore d'avis pour ce produit

Références scientifiques

Ettinger B, Pak CY, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997 Dec;158(6):2069-73.
Massey L. Magnesium therapy for nephrolithiasis. Magne Res. 2005 Jun;18(2):123-6. Review.
Do Monte FH, dos Santos JG Jr, et al. Antinociceptive and anti-inflammatory properties of the hydroalcoholic extract of stems from Equisetum arvense L. in mice. Pharmacol Res. 2004 Mar;49(3):239-43.
Tiktinskii OL, Bablumian IA. [Therapeutic action of Java tea and field horsetail in uric acid diathesis]. Urol Nefrol (Mosk) 1983;3(1):47-50.
Schutz K, Carle R, Schieber A. Taraxacum--a review on its phytochemical and pharmacological profile. J Ethnopharmacol. 2006 Oct 11;107(3):313-23.
Barros ME, Schor N, Boim MA. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro. Urol Res. 2003 Feb;30(6):374-9. Epub 2003 Jan 21.
Boim MA, Heilberg IP, Schor N. Phyllanthus niruri as a promising alternative treatment for nephrolithiasis. Int Braz J Urol. 2010 Nov-Dec;36(6):657-64; discussion 664.
Freitas AM, Schor N, Boim MA. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU Int. 2002 Jun;89(9):829-34.
Micali S, Sighinolfi MC, Celia A, De Stefani S, Grande M, Cicero AF, Bianchi G. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol. 2006 Sep;176(3):1020-2.
Grases F, Costa-Bauzá A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res. 1999 Sep-Oct;19(5A):3717-22.
Curhan GC, Willett WC, et al. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999 Apr;10(4):840-5.
Niroomand H, Ziaee A, Ziaee K, Gheissari A. Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy on kidney stone size. Adv Biomed Res. 2016;5:168. Published 2016 Oct 26. doi:10.4103/2277-9175.192629
Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Vitamin B6 intake and the risk of incident kidney stones. Urolithiasis. 2018;46(3):265-270. doi:10.1007/s00240-017-0999-5
Mimica-Dukic N, Simin N, Cvejic J, Jovin E, Orcic D, Bozin B. Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants. Molecules. 2008;13(7):1455-1464. Published 2008 Jul 17. doi:10.3390/molecules13071455
Carneiro DM, Freire RC, Honório TC, et al. Randomized, Double-Blind Clinical Trial to Assess the Acute Diuretic Effect of Equisetum arvense (Field Horsetail) in Healthy Volunteers. Evid Based Complement Alternat Med. 2014;2014:760683. doi:10.1155/2014/760683
Grases F, Costa-Bauzá A. Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res. 1999;19(5A):3717-3722.
Lee NY, Khoo WK, Adnan MA, Mahalingam TP, Fernandez AR, Jeevaratnam K. The pharmacological potential of Phyllanthus niruri. J Pharm Pharmacol. 2016;68(8):953-969. doi:10.1111/jphp.12565
Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-165. doi:10.1016/j.eururo.2012.03.052